HLTRF
Price
$3.75
Change
+$0.01 (+0.27%)
Updated
Aug 15 closing price
Capitalization
116.73M
INIS
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
46.37M
Interact to see
Advertisement

HLTRF vs INIS

Header iconHLTRF vs INIS Comparison
Open Charts HLTRF vs INISBanner chart's image
HLS Therapeutics
Price$3.75
Change+$0.01 (+0.27%)
Volume$100
Capitalization116.73M
International Isotopes
Price$0.09
Change-$0.00 (-0.00%)
Volume$20.44K
Capitalization46.37M
HLTRF vs INIS Comparison Chart in %
Loading...
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLTRF vs. INIS commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLTRF is a Hold and INIS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (HLTRF: $3.75 vs. INIS: $0.09)
Brand notoriety: HLTRF and INIS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLTRF: 3% vs. INIS: 15%
Market capitalization -- HLTRF: $116.73M vs. INIS: $46.37M
HLTRF [@Pharmaceuticals: Generic] is valued at $116.73M. INIS’s [@Pharmaceuticals: Generic] market capitalization is $46.37M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLTRF’s FA Score shows that 1 FA rating(s) are green whileINIS’s FA Score has 1 green FA rating(s).

  • HLTRF’s FA Score: 1 green, 4 red.
  • INIS’s FA Score: 1 green, 4 red.
According to our system of comparison, both HLTRF and INIS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLTRF’s TA Score shows that 5 TA indicator(s) are bullish while INIS’s TA Score has 3 bullish TA indicator(s).

  • HLTRF’s TA Score: 5 bullish, 2 bearish.
  • INIS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HLTRF is a better buy in the short-term than INIS.

Price Growth

HLTRF (@Pharmaceuticals: Generic) experienced а +1.63% price change this week, while INIS (@Pharmaceuticals: Generic) price change was -17.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLTRF($117M) has a higher market cap than INIS($46.4M). INIS YTD gains are higher at: 156.105 vs. HLTRF (39.405). HLTRF has higher annual earnings (EBITDA): 17.7M vs. INIS (779K). HLTRF has more cash in the bank: 17.7M vs. INIS (1.65M). INIS has less debt than HLTRF: INIS (4.9M) vs HLTRF (63.7M). HLTRF has higher revenues than INIS: HLTRF (56.8M) vs INIS (14.2M).
HLTRFINISHLTRF / INIS
Capitalization117M46.4M252%
EBITDA17.7M779K2,272%
Gain YTD39.405156.10525%
P/E RatioN/AN/A-
Revenue56.8M14.2M400%
Total Cash17.7M1.65M1,075%
Total Debt63.7M4.9M1,300%
FUNDAMENTALS RATINGS
HLTRF vs INIS: Fundamental Ratings
HLTRF
INIS
OUTLOOK RATING
1..100
9384
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
9588
PRICE GROWTH RATING
1..100
4237
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HLTRF's Valuation (25) in the null industry is somewhat better than the same rating for INIS (85). This means that HLTRF’s stock grew somewhat faster than INIS’s over the last 12 months.

INIS's Profit vs Risk Rating (89) in the null industry is in the same range as HLTRF (100). This means that INIS’s stock grew similarly to HLTRF’s over the last 12 months.

INIS's SMR Rating (88) in the null industry is in the same range as HLTRF (95). This means that INIS’s stock grew similarly to HLTRF’s over the last 12 months.

INIS's Price Growth Rating (37) in the null industry is in the same range as HLTRF (42). This means that INIS’s stock grew similarly to HLTRF’s over the last 12 months.

INIS's P/E Growth Rating (5) in the null industry is significantly better than the same rating for HLTRF (100). This means that INIS’s stock grew significantly faster than HLTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HLTRFINIS
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 11 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
38%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFHO1.020.03
+3.03%
Pacific Health Care Organization, Inc.
WILLF39.060.92
+2.41%
Demant AS
KMMPF12.96N/A
N/A
Killiam Apt Real Estate Invt Tr
PRMY25.00N/A
N/A
Primary Bk
DBSDY158.39-0.96
-0.60%
DBS Group Holdings Ltd.

HLTRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLTRF has been loosely correlated with LBTSF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLTRF jumps, then LBTSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLTRF
1D Price
Change %
HLTRF100%
+0.27%
LBTSF - HLTRF
38%
Loosely correlated
N/A
INIS - HLTRF
17%
Poorly correlated
+3.65%
ETST - HLTRF
12%
Poorly correlated
+7.89%
HKMPF - HLTRF
11%
Poorly correlated
N/A
GTBIF - HLTRF
8%
Poorly correlated
-12.40%
More

INIS and

Correlation & Price change

A.I.dvisor tells us that INIS and HLTRF have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INIS and HLTRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INIS
1D Price
Change %
INIS100%
+3.65%
HLTRF - INIS
17%
Poorly correlated
+0.27%
GRUSF - INIS
10%
Poorly correlated
-3.00%
HSTI - INIS
9%
Poorly correlated
N/A
HYPMY - INIS
3%
Poorly correlated
+4.58%
IPSEF - INIS
2%
Poorly correlated
N/A
More